Surrozen, Inc.
Surrozen is dedicated to unlocking the body's regenerative power to treat injury and disease through innovative platforms and programs. Their mission is to repair, restore, and renew, leveraging Wnt biology and other cutting-edge research to develop therapies for various health conditions.
Industries
biotechnology
emergency-medicine
health-care
Nr. of Employees
small (1-50)
Surrozen, Inc.
South San Francisco, California, United States, North America
Products
Lead Wnt pathway-targeting therapeutic candidate (clinical program)
A biologic therapeutic candidate developed to modulate Wnt signaling for regenerative indications; listed on the company's programs/pipeline pages as a lead program.
Lead Wnt pathway-targeting therapeutic candidate (clinical program)
A biologic therapeutic candidate developed to modulate Wnt signaling for regenerative indications; listed on the company's programs/pipeline pages as a lead program.
Services
Research and development of regenerative therapeutics
Discovery and preclinical development of therapeutic candidates that modulate Wnt signaling to promote tissue repair.
Research and development of regenerative therapeutics
Discovery and preclinical development of therapeutic candidates that modulate Wnt signaling to promote tissue repair.
Expertise Areas
- Wnt signaling biology
- Regenerative medicine research
- Therapeutic biologics discovery
- Preclinical and pipeline program development
Key Technologies
- Wnt pathway modulation
- Engineered protein/biologic platform for signaling agonists
- Preclinical therapeutic development
- Research governance and FCOI reporting workflows